HilleVax, Inc.
NASDAQ:HLVX
1.9 (USD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Assets: | |||||
Current Assets: | |||||
Cash & Cash Equivalents
| 216.678 | 279.401 | 124.566 | 0.457 | 0.403 |
Short Term Investments
| 86.805 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 303.483 | 279.401 | 124.566 | 0.457 | 0.403 |
Net Receivables
| 0 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 7.195 | 11.212 | 0.141 | 0.048 | 0.048 |
Total Current Assets
| 310.678 | 290.613 | 124.707 | 0.505 | 0.451 |
Non-Current Assets: | |||||
Property, Plant & Equipment, Net
| 32.1 | 24.945 | 0.231 | 0 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 1.631 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 1.656 | 0.022 | 2.221 | 0 | 0 |
Total Non-Current Assets
| 33.756 | 26.598 | 2.452 | 0 | 0 |
Total Assets
| 344.434 | 317.211 | 127.159 | 0.505 | 0.451 |
Liabilities & Equity: | |||||
Current Liabilities: | |||||
Account Payables
| 7.461 | 4.744 | 1.024 | 0.13 | 0.202 |
Short Term Debt
| 6.236 | 0.074 | 158.308 | 3.024 | 0.906 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 11.985 | 0 | -0 |
Other Current Liabilities
| 15.569 | 8.228 | 68.43 | 0.124 | 0.014 |
Total Current Liabilities
| 29.266 | 13.046 | 227.762 | 3.278 | 1.122 |
Non-Current Liabilities: | |||||
Long Term Debt
| 48.075 | 36.361 | 0.153 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 1.568 | 0.575 | 0.001 | 0 | 0 |
Total Non-Current Liabilities
| 49.643 | 36.936 | 0.154 | 0 | 0 |
Total Liabilities
| 78.909 | 49.982 | 227.916 | 3.278 | 1.122 |
Equity: | |||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 |
Common Stock
| 0.005 | 0.004 | 0.001 | 0 | 0 |
Retained Earnings
| -388.559 | -264.993 | -105.184 | -2.776 | -0.673 |
Accumulated Other Comprehensive Income/Loss
| -0.907 | -0.281 | -0 | -0 | 0 |
Other Total Stockholders Equity
| 654.986 | 532.499 | 4.426 | 0.003 | 0.002 |
Total Shareholders Equity
| 265.525 | 267.229 | -100.757 | -2.773 | -0.671 |
Total Equity
| 265.525 | 267.229 | -100.757 | -2.773 | -0.671 |
Total Liabilities & Shareholders Equity
| 344.434 | 317.211 | 127.159 | 0.505 | 0.451 |